-
1 . Academic Journal
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial
- 저자
- by Adams, Luthando; Ally, Mahmood M; du Plooy, Maria C; Louw, Ingrid C; Nayiager, Savithree, et al.
- 소스
- In The Lancet 29 July-4 August 2017 390(10093):457-468
-
7 . Periodical
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial
- 저자
- by Fleischmann, Roy; Mysler, Eduardo; Hall, Stephen; Kivitz, Alan J; Moots, Robert J, et al.
- 소스
- The Lancet; July-August 2017, Vol. 390 Issue: 10093 p457-468, 12p